Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

SS Innovations International, Inc. (SSII) Financial Statements

SS Innovations International, Inc. (SSII) reported trailing twelve-month revenue of $52.4M (up 105.7% year on year) and net income of -$12.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$18.2M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SSIISS Innovations International, Inc.Follow SSII — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
450.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue5.920.642.552.4
Gross profit0.78.519.525.0
Research & development1.12.53.75.6
Operating income-20.3-19.0-8.2-8.5
Pre-tax income-20.9-19.2-8.2-8.2
Income tax——4.04.3
Net income-20.9-19.2-12.1-12.4
Diluted EPS ($)-0.14-0.11-0.06-0.06
Diluted shares (mn)152.1181.2198.7—

USD millions · SEC XBRL

SS Innovations International, Inc. — questions

What is SS Innovations International, Inc.'s revenue?
$52.4M over the twelve months to 2026-06-30, up 105.7% year on year, from its 10-Q and 10-K filings.
What is SS Innovations International, Inc.'s net income?
-$12.4M over the twelve months to 2026-06-30.
What is SS Innovations International, Inc.'s free cash flow?
-$18.2M over the twelve months to 2026-06-30.
What are SS Innovations International, Inc.'s diluted earnings per share?
$-0.06 over the twelve months to 2026-06-30.

Every figure on this page comes from SS Innovations International, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.